Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone versus placebo in ataxia telangiectasia
ISRCTN08774933Phase 2Completed
- Sponsor
- Fondazione Monte dei Paschi di Siena
- Start
- Nov 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of betamethasone in ataxia-telangiectasia (AT) (2 arms), sponsored by Fondazione Monte dei Paschi di Siena. Primary endpoint: Neurological symptoms. Started Nov 2008; status: completed.
02
Drugs
betamethasone
03
Conditions
ataxia-telangiectasia (AT)
Beyond the preview
Go deeper on ISRCTN08774933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN08774933.